Company ESG Risk Ratings

Company ESG Risk Ratings

Pfizer Inc

Industry Group: Pharmaceuticals

Country: United States

Identifier: NYS:PFE

ESG Risk Rating

24.7
Medium
Risk
0-10
10-20
20-30
30-40
40+

Ranking

Industry Group

Pharmaceuticals 80 out of 888


Universe

Global Universe 5326 out of 14051


Last Update: May 12, 2021
Sustainalytics ESG Risk Ratings are typically updated once per year. However, scoring and qualitative assessments can be updated more frequently due to events assessment changes and corporate governance assessment changes, which are updated according to more frequent and different update cycles.
What are the ESG Risk Ratings?
More information for Corporates | Banks and Lenders | Investors

Industry Comparison

ESG RISK RATING INDUSTRY RANK
Novartis AG
17.0
 
 
 
 
 
Low
7 out of 888
Merck & Co Inc
23.0
 
 
 
 
 
Med.
66 out of 888
Pfizer Inc
24.7
 
 
 
 
 
Med.
80 out of 888
AbbVie Inc
27.4
 
 
 
 
 
Med.
121 out of 888
Eli Lilly & Co.
29.1
 
 
 
 
 
Med.
146 out of 888
For corporate professionals interested in direct competitor insights

Sustainalytics' Peer Performance Insights gives an in-depth analysis of your company’s ESG strengths and weaknesses compared to your competitors and industry performance. These insights can be used to identify areas of ESG improvement to help inform future management decisions that align with your organization’s sustainability goals.

Our Approach to Calculating ESG Risk

The ESG Risk Ratings measure a company’s exposure to industry-specific material ESG risks and how well a company is managing those risks.

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues. Our exposure score takes into consideration subindustry and company-specific factors such as its business model.

Pfizer Inc's Exposure is Medium

Management

Management refers to how well a company is managing its relevant ESG issues. Our management score assesses the robustness of a company’s ESG programs, practices and policies.

Pfizer Inc's Management of ESG Material Risk is Strong

How do the ESG Risk Ratings work?

Top Material ESG Issues for Pfizer Inc

Understand how exposed companies are to specific material ESG issues and how well companies are managing these issues.

What are Material ESG Issues?

Material ESG issues are issues that are considered to be financially material to a given company in a relevant sub-industry.

Controversy Rating

Highest Controversy level that has impacted Pfizer Inc's ESG Risk Rating in the last three years

Highest Controversy Level

Contributing Events

Our controversies research identifies companies involved in incidents that may negatively impact stakeholders, the environment or the company's operations.

Controversies form an important component of the ESG Risk Ratings as they can act as signals that management initiatives were insufficient or ineffective.

Learn how the ESG Risk Ratings are used by our clients

Corporates

Leverage Sustainalytics' ESG Risk Ratings to understand and promote your corporate ESG performance with internal and external stakeholders.

Banks and Lenders

Banks and lenders can use our ESG Risk Ratings and data as a part of a broader analysis of their clients as well as for innovative product solutions such as sustainability linked loans.

Investors

The ESG Risk Ratings can help investors to identify, understand and manage ESG risks at the security and portfolio level with the aim of improving the long-term performance of their equity and fixed income securities.